Launch

Launch Your Merch FREE 4-Day Challenge Empowers Entrepreneurs to Build Profitable Merch Stores Online

Retrieved on: 
Lunedì, Maggio 20, 2024
The Launch, Launch, Entrepreneurship, Blog, Small business, Marketing, E-commerce, Curriculum, PST, Knowledge, Online shopping

It will offer participants a comprehensive curriculum covering all aspects of starting and growing an online brand and eCommerce business.

Key Points: 
  • It will offer participants a comprehensive curriculum covering all aspects of starting and growing an online brand and eCommerce business.
  • "We believe that by sharing  access to knowledge, wisdom, and resources, we can unlock the entrepreneurial potential of aspiring entrepreneurs and help them build successful online businesses."
  • Launch Your Merch Challenge participants will benefit from the following:
    4 Days of expert-led training covering key topics such as product design, product sourcing, eCommerce, and branding.
  • The Launch Your Merch Challenge is open to individuals of all backgrounds and experience levels, from seasoned entrepreneurs to those just starting their journey in the merchandise industry.

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress

Retrieved on: 
Martedì, Maggio 14, 2024
Sickle cell disease, Grady Memorial Hospital, EHA, Harvard Medical School, Hospital, Central European, Hereditary spherocytosis, Winship Cancer Institute, Abstract, University Medical Center, MMSc, All but dissertation, AGIO, American University of Beirut, Launch, Disease, Anemia, Thalassemia, Hematology, Utrecht University, University, Hydroxycarbamide, University Medical Center Utrecht, Oncology, Iron overload, American University, Pharmaceutical industry

CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that data from its programs will be presented at the European Hematology Association 2024 (EHA2024) Hybrid Congress, to be held June 13-16, 2024, in Madrid, Spain.

Key Points: 
  • Additional presentations will highlight data across Agios’ pipeline in rare blood disorders, including sickle cell disease and pyruvate kinase deficiency.
  • In total, seven abstracts led by Agios and external collaborators will be presented or published.
  • The accepted abstracts are listed below and are available online on the EHA congress website at www.ehaweb.org.
  • Data from the global Phase 3 ENERGIZE study of mitapivat in alpha- or beta- non-transfusion-dependent thalassemia.

RSA to Demonstrate Identity Security Innovations Critical to Meeting NIST CSF 2.0 and Eliminating Passwords at RSA Conference 2024

Retrieved on: 
Martedì, Maggio 7, 2024
Data Management, Security, Technology, Mobile, Wireless, Software, Hardware, FIDO, Launch, Android, BYOA, AI, Conference, Research, Gold, QR, Booth, Organization, OATH, OTP, JML, CSF, FIDO2, Private sector, RSAC, NIST, ID, RSA, IOS, Architecture, Risk management

RSA, the security-first identity leader, announced new product enhancements at RSA Conference 2024 to help organizations meet the National Institute of Standards and Technology’s Cybersecurity Framework 2.0 ( NIST CSF 2.0 ) advanced security standards and eliminate passwords.

Key Points: 
  • RSA, the security-first identity leader, announced new product enhancements at RSA Conference 2024 to help organizations meet the National Institute of Standards and Technology’s Cybersecurity Framework 2.0 ( NIST CSF 2.0 ) advanced security standards and eliminate passwords.
  • Specifically, CSF 2.0 addresses a threat landscape now dominated by identity-driven threats and makes extensive recommendations to counteract them.
  • “NIST CSF 2.0 makes it clear that, no matter the size and no matter the sector, every organization is only as secure as its identities,” said RSA CEO Rohit Ghai.
  • “The tech industry shapes identity, and identity shapes the world,” said RSA CMO Laura Marx.

Rocket Lab Announces First Quarter 2024 Financial Results Reflecting Year-on-Year Revenue Growth of 69%, Sequential Quarterly Growth of 55%, and Continued Growth in Q2 2024

Retrieved on: 
Lunedì, Maggio 6, 2024
Technology, Aerospace, Manufacturing, Satellite, Neutron, Space Development Agency, Archimedes, Table, Launch, United, Electron, Lab, Launch Complex 3, MDA, NASA, Globalstar, Webcast, Spacecraft, John C. Stennis, Ground Intelligence Officer, Rocket Lab, Defense, Tranche, Interest expense, Varda, Transport, KAIST, SSL (company), GAAP, Communications satellite

Meaningful progress made on the production and testing of two Rocket Lab spacecraft for NASA’s ESCAPADE mission to Mars.

Key Points: 
  • Meaningful progress made on the production and testing of two Rocket Lab spacecraft for NASA’s ESCAPADE mission to Mars.
  • For the second quarter of 2024, Rocket Lab expects:
    Revenue between $105 million and $110 million.
  • ET) today to discuss these business highlights and financial results for our first quarter, to provide our outlook for the second quarter, and other updates.
  • The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events .

NASA Sets Coverage for Boeing Starliner's First Crewed Launch, Docking

Retrieved on: 
Lunedì, Aprile 29, 2024
Blog, Suni, Launch, EDT, International Space Station, Space Coast, News, United Launch Alliance, Space launch, Atlas, Starliner, NASA TV, Commercial Crew Program, Policy, Television, NASA, ULA, UHF, Accreditation, Harmony, Boeing, VHF, Hertz, NASA Social, Communications satellite

1:30 p.m. – Virtual news conference at Kennedy with the flight test astronauts:

Key Points: 
  • 1:30 p.m. – Virtual news conference at Kennedy with the flight test astronauts:
    Coverage of the virtual news conference will stream live on NASA+ , NASA Television, the NASA app , YouTube , and the agency's website .
  • 6:30 p.m. – Launch coverage begins on NASA+ , NASA Television, the NASA app , YouTube , and the agency's website .
  • NASA+ will resume coverage and NASA Television's media channel will break from in-orbit coverage to carry the postlaunch news conference.
  • Once the postlaunch news conference is complete, NASA+ coverage will end, and mission coverage will continue on both NASA channels.

Novartis’ Intravenous Formulation of Cosentyx Impacting Prescriber Preferences in Psoriatic Arthritis Treatment, While Pending Launch of UCB’s Bimzelx Poised to Further Disrupt the Market

Retrieved on: 
Martedì, Aprile 16, 2024
Psoriatic arthritis, Launch, HCP, Rheumatology, Patient, Need for Speed, Benchmarking, MOA, RealTime, IL-17A, Growth, Overalls, Ankylosing spondylitis, Pharmaceutical industry

Approximately five months post-approval, over one-third of US rheumatologists (n=104) report prescribing the IV formulation for their patients with PsA.

Key Points: 
  • Approximately five months post-approval, over one-third of US rheumatologists (n=104) report prescribing the IV formulation for their patients with PsA.
  • Furthermore, the vast majority feel the new formulation of Novartis’ IL-17-inhibitor brings some degree of advance over existing PsA treatments.
  • Receptivity to the IV formulation has also resulted in a greater affinity for the Cosentyx brand overall, specifically in comparison to long-standing IL-17 rival, Eli Lilly’s Taltz.
  • Launch tracking of Bimzelx will commence following approval and will continue for the first eighteen months of availability through the Launch Dynamix™ service.

Tineco Announces the Launch of the Floor One S7 FlashDry, Revolutionizing Cleaning!

Retrieved on: 
Mercoledì, Aprile 24, 2024
Technology, Retail, Home Goods, Consumer Electronics, Launch, Corner, Water, Floor, Movement, Multimedia, Recycling, Sulfur

Tineco, a specialist in floor care and smart appliances, launches the Tineco Floor One S7 FlashDry, a breakthrough in intelligent cleaning.

Key Points: 
  • Tineco, a specialist in floor care and smart appliances, launches the Tineco Floor One S7 FlashDry, a breakthrough in intelligent cleaning.
  • View the full release here: https://www.businesswire.com/news/home/20240424832533/en/
    Tineco Announces the Launch of the Floor One S7 FlashDry, Revolutionizing Cleaning!
  • (Photo: Business Wire)
    The Tineco Floor One S7 FlashDry is designed to deliver an effortless cleaning experience and impeccable results.
  • The Tineco Floor One S7 FlashDry is available in multiple options, including the Floor One S7 Combo and the Floor One S7 Pro, to meet the specific needs of each household.

PDP Celebrates Fortnite Festival Season 3 With the Launch of the RIFFMASTER Wireless Guitar Controller

Retrieved on: 
Martedì, Aprile 23, 2024
Generation Z, Retail, Teens, Men, TV and Radio, Online Retail, Electronic Games, Consumer, Department Stores, Consumer Electronics, Technology, Entertainment, Public Relations, Investor Relations, Millennials, Online, Mobile Entertainment, Communications, General Entertainment, PS5, Launch, Rock Band, MSRP, Rock Band 4, News, Performance, Xbox, Turtle Beach Corporation, PDP, Amazon, Product management, PlayStation, Xbox One, Multimedia, PS4, Video game

Leading gaming accessory maker Turtle Beach Corporation (Nasdaq: HEAR), and Performance Designed Products LLC (PDP) today announced the official launch of PDP’s highly-coveted RIFFMASTER wireless guitar controller ($129.99 MSRP).

Key Points: 
  • Leading gaming accessory maker Turtle Beach Corporation (Nasdaq: HEAR), and Performance Designed Products LLC (PDP) today announced the official launch of PDP’s highly-coveted RIFFMASTER wireless guitar controller ($129.99 MSRP).
  • The RIFFMASTER is the first guitar controller designed for today’s rhythm-action gamers and is compatible with Fortnite Festival Pro Lead and Pro Bass song parts in addition to Rock Band™ 4.
  • View the full release here: https://www.businesswire.com/news/home/20240423402701/en/
    PDP Celebrates Fortnite Festival Season 3 with the Launch of the Riffmaster Wireless Guitar Controller (Graphic: Business Wire)
    Pre-orders for the RIFFMASTER sold out just hours following its debut last month.
  • Fans that pre-ordered their RIFFMASTER early are receiving their controllers now during this initial wave of its rolling launch.

NextPlat Reports Consolidated Year-End 2023 Results with Increased Revenues of $37.8 Million, Record Annual Margins of 30% and $26.3 Million in Cash

Retrieved on: 
Giovedì, Aprile 11, 2024
Launch, Executive, Pharmacy, OTCQB, Dietary supplement, Health, Depreciation, Security (finance), Partnership, Growth, Ali Baba, Global Operations, Acquisition, Form 10-K, Immunity

COCONUT GROVE, Fla., April 11, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced the financial results for the fiscal year-ended December 31, 2023 which consolidates the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care").

Key Points: 
  • Results for the full year ended December 2023 reflect e-commerce revenue of approximately $11.0 million and approximately $26.8 million in revenue contributed from the Company's healthcare operations (specifically, Progressive Care whose results are consolidated as of July 1, 2023).
  • Operating expenses for the year ended December 31, 2023, were approximately $34.5 million compared to approximately $9.7 million in the year-ago period.
  • Operating expenses in 2023 also included a non-cash goodwill impairment charge of approximately $13.9 million related to the Progressive Care acquisition.
  • On March 1, 2024, NextPlat launched the exclusive OPKO Healthcare ("OPKO")-branded storefront in China on Alibaba's Tmall Global platform.

US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Retrieved on: 
Venerdì, Aprile 5, 2024
Launch, Benchmarking, Liver, Patient, Gastroenterology, Weight loss, Market, Pulse, Fibrosis, NASH, FDA, Pharmaceutical industry

As anticipation builds for the launch of Rezdiffra, Spherix Global Insights recently conducted a pulse survey among gastroenterologists (n=81) to assess prescriber feedback and projected uptake of the brand post-launch.

Key Points: 
  • As anticipation builds for the launch of Rezdiffra, Spherix Global Insights recently conducted a pulse survey among gastroenterologists (n=81) to assess prescriber feedback and projected uptake of the brand post-launch.
  • Furthermore, 70% of gastroenterologists in the March 2024 pulse now report they are at least moderately familiar with Rezdiffra, a significant increase compared to April 2023.
  • When discussing the primary benefits of Rezdiffra, gastroenterologists highlight its distinction as the first indicated product for MASH, alongside its prospective efficacy in improving fibrosis.
  • Furthermore, gastroenterologists indicate that over one-third of MASH patients under their care would be suitable candidates for Rezdiffra, further bolstering the likelihood of swift uptake and utilization.